Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions
Filter
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
ABEO
Abeona Therapeutics
Alvino Mark
/
director
01/21/2025
Sell
$5.10
4,000
$20K
68,334
NASDAQ
ACCD
Accolade
SINGH RAJEEV
/
director, officer: Chief Executive Officer
01/17/2025
Sell
$6.86
309
$2K
820,211
NASDAQ
ACCD
Accolade
Cavanaugh Robert N
/
officer: President
01/17/2025
Sell
$6.86
186
$1K
215,089
NASDAQ
ACCD
Accolade
Barnes Stephen H.
/
officer: Chief Financial Officer
01/17/2025
Sell
$6.86
154
$1K
222,244
NASDAQ
ADAP
Adaptimmune Therapeutics
Rawcliffe Adrian
/
director, officer: Chief Executive Officer
01/17/2025
Sell
$0.58
30,601
$18K
44,327
NASDAQ
ADAP
Adaptimmune Therapeutics
Norry Elliot
/
officer: Chief Medical Officer
01/13/2025
Sell
$0.59
4,268
$3K
5,845
NASDAQ
ADAP
Adaptimmune Therapeutics
Bertrand William C JR
/
officer: Chief Operating Officer
01/13/2025
Sell
$0.59
5,471
$3K
7,623
NASDAQ
ADAP
Adaptimmune Therapeutics
Rawcliffe Adrian
/
director, officer: Chief Executive Officer
01/13/2025
Sell
$0.59
12,539
$7K
17,801
NASDAQ
ADAP
Adaptimmune Therapeutics
Bertrand William C JR
/
officer: Chief Operating Officer
01/17/2025
Sell
$0.58
5,584
$3K
7,510
NASDAQ
ADAP
Adaptimmune Therapeutics
Norry Elliot
/
officer: Chief Medical Officer
01/13/2025
Sell
$0.59
8,124
$5K
11,516
NASDAQ
ADAP
Adaptimmune Therapeutics
Bertrand William C JR
/
officer: Chief Operating Officer
01/15/2025
Sell
$0.57
9,803
$6K
13,756
NASDAQ
ADAP
Adaptimmune Therapeutics
Rawcliffe Adrian
/
director, officer: Chief Executive Officer
01/13/2025
Sell
$0.59
17,934
$11K
25,711
NASDAQ
ADAP
Adaptimmune Therapeutics
Norry Elliot
/
officer: Chief Medical Officer
01/15/2025
Sell
$0.57
9,803
$6K
13,756
NASDAQ
ADAP
Adaptimmune Therapeutics
Rawcliffe Adrian
/
director, officer: Chief Executive Officer
01/15/2025
Sell
$0.57
29,096
$17K
41,582
NASDAQ
ADAP
Adaptimmune Therapeutics
Lunger John
/
officer: Chief Patient Supply Officer
01/17/2025
Sell
$0.58
5,584
$3K
7,510
NASDAQ
ADAP
Adaptimmune Therapeutics
Lunger John
/
officer: Chief Patient Supply Officer
01/13/2025
Sell
$0.59
4,268
$3K
5,845
NASDAQ
ADAP
Adaptimmune Therapeutics
Norry Elliot
/
officer: Chief Medical Officer
01/17/2025
Sell
$0.58
5,584
$3K
7,510
NASDAQ
ADAP
Adaptimmune Therapeutics
Lunger John
/
officer: Chief Patient Supply Officer
01/13/2025
Sell
$0.59
5,471
$3K
7,623
NASDAQ
ADAP
Adaptimmune Therapeutics
Lunger John
/
officer: Chief Patient Supply Officer
01/15/2025
Sell
$0.57
9,803
$6K
13,756
NASDAQ
ADAP
Adaptimmune Therapeutics
Bertrand William C JR
/
officer: Chief Operating Officer
01/13/2025
Sell
$0.59
4,268
$3K
5,845
NASDAQ
ADAP
Adaptimmune Therapeutics
Piccina Cintia
/
officer: Chief Commercial Officer
01/15/2025
Sell
$0.57
12,991
$7K
18,421
NASDAQ
ANIX
Anixa Biosciences
Catelani Michael
/
officer: President, COO, & CFO
01/15/2025
Buy
$2.15
9,289
$20K
44,500
NASDAQ
ANIX
Anixa Biosciences
KUMAR AMIT
/
officer: Chief Executive Officer
01/15/2025
Buy
$2.23
43,000
$96K
559,925
NASDAQ
ANIX
Anixa Biosciences
Titterton Lewis H jr
/
director
01/21/2025
Buy
$2.59
6,000
$16K
928,334
NASDAQ
APLS
Apellis Pharmaceuticals
Lewis Karen
/
officer: Chief People Officer
01/17/2025
Sell
$29.96
1,241
$37K
43,858
NASDAQ
APLS
Apellis Pharmaceuticals
DeLong Mark Jeffrey
/
officer: Chief Business & Strat Officer
01/17/2025
Sell
$29.96
1,235
$37K
57,561
NASDAQ
APLS
Apellis Pharmaceuticals
Nicholson Nur
/
officer: Chief Technical Officer
01/17/2025
Sell
$29.96
2,145
$64K
52,011
NASDAQ
APLS
Apellis Pharmaceuticals
Sullivan Timothy Eugene
/
officer: Chief Financial Officer
01/17/2025
Sell
$29.96
1,730
$52K
86,370
NASDAQ
APLS
Apellis Pharmaceuticals
Townsend Adam J.
/
officer: Chief Commercial Officer
01/17/2025
Sell
$29.96
2,201
$66K
88,068
NASDAQ
APLS
Apellis Pharmaceuticals
Deschatelets Pascal
/
officer: Chief Scientific Officer
01/17/2025
Sell
$29.96
750
$22K
1.14M
NASDAQ
APLS
Apellis Pharmaceuticals
Watson David O.
/
officer: General Counsel
01/17/2025
Sell
$29.96
2,201
$66K
105,555
NASDAQ
APLS
Apellis Pharmaceuticals
Baumal Caroline
/
officer: Chief Medical Officer
01/17/2025
Sell
$29.96
1,853
$56K
53,707
NASDAQ
APLS
Apellis Pharmaceuticals
Francois Cedric
/
director, officer: Chief Executive Officer
01/17/2025
Sell
$29.96
6,007
$180K
301,408
NASDAQ
APLS
Apellis Pharmaceuticals
Chopas James George
/
officer: VP/Chief Accounting Officer
01/17/2025
Sell
$29.96
715
$21K
36,643
NASDAQ
ACLX
Arcellx
Patel Kavita
/
director
01/14/2025
Sell
$67.32
300
$20K
0
NASDAQ
ACLX
Arcellx
Patel Kavita
/
director
01/14/2025
Sell
$66.62
400
$27K
300
NASDAQ
ACLX
Arcellx
Patel Kavita
/
director
01/14/2025
Sell
$64.95
800
$52K
700
NASDAQ
AVIR
Atea Pharmaceuticals
BERGER FRANKLIN M
/
director
01/15/2025
Sell
$3.19
15,000
$48K
466,897
NASDAQ
AVIR
Atea Pharmaceuticals
BERGER FRANKLIN M
/
director
01/16/2025
Sell
$3.36
10,000
$34K
476,897
NASDAQ
AURA
Aura Biosciences
Elazzouzi Amy
/
officer: Vice President, Finance
01/21/2025
Sell
$7.67
1,001
$8K
38,442
NASDAQ
AURA
Aura Biosciences
de los Pinos Elisabet
/
director, officer: See Remarks
01/21/2025
Sell
$7.67
15,955
$122K
304,692
NYSE
BDX
Becton Dickinson
Shan David
/
officer: EVP and Chief ISC Officer
01/21/2025
Sell
$240.00
500
$120K
5,741
NYSE
BDX
Becton Dickinson
Garrison Michael David
/
officer: EVP & President, Medical
01/17/2025
Sell
$236.51
597
$141K
5,544
NYSE
BDX
Becton Dickinson
Neal Shana Carol
/
officer: EVP and Chief People Officer
01/21/2025
Sell
$240.00
787
$189K
15,414
NASDAQ
BVS
Bioventus
Claypoole Robert E
/
director, officer: President and CEO
01/13/2025
Sell
$9.10
28,786
$262K
64,964
NASDAQ
CADL
Candel Therapeutics
Nichols William Garrett
/
officer: Chief Medical Officer
01/15/2025
Sell
$7.23
10,428
$75K
79,320
NASDAQ
CADL
Candel Therapeutics
Tak Paul Peter
/
director, officer: Chief Executive Officer
01/15/2025
Sell
$7.23
21,704
$157K
251,912
NASDAQ
CADL
Candel Therapeutics
Schoch Charles
/
officer: See Remarks
01/15/2025
Sell
$7.23
9,511
$69K
43,038
NASDAQ
CADL
Candel Therapeutics
Tyagarajan Seshu
/
officer: Chief Technology Officer
01/15/2025
Sell
$7.23
14,322
$103K
96,790
NASDAQ
CADL
Candel Therapeutics
Barone Francesca
/
officer: Chief Scientific Officer
01/15/2025
Sell
$7.23
13,534
$98K
110,673
NASDAQ
RNAC
Cartesian Therapeutics
SPRINGER TIMOTHY A
/
director, 10 percent owner:
01/13/2025
Buy
$16.86
7,962
$134K
8.52M
NASDAQ
RNAC
Cartesian Therapeutics
SPRINGER TIMOTHY A
/
director, 10 percent owner:
01/13/2025
Buy
$17.78
8,983
$160K
8.53M
NASDAQ
RNAC
Cartesian Therapeutics
SPRINGER TIMOTHY A
/
director, 10 percent owner:
01/14/2025
Buy
$18.00
4,022
$72K
8.53M
NASDAQ
CNTA
Centessa Pharmaceuticals
HUSSAIN IQBAL J
/
officer: General Counsel
01/15/2025
Sell
$15.29
6,000
$92K
118,265
NASDAQ
COGT
Cogent Biosciences
Pinnow Cole
/
officer: Chief Commercial Officer
01/14/2025
Buy
$7.60
43,750
$332K
45,848
NASDAQ
CORT
Corcept Therapeutics
Swisher Daniel N JR
/
director
01/10/2025
Sell
$50.54
2,200
$111K
0
NASDAQ
COSM
Cosmos Health
Siokas Grigorios
/
director, 10 percent owner, officer: Chief Executive Officer
01/14/2025
Buy
$0.69
87,247
$60K
4.03M
NASDAQ
COSM
Cosmos Health
Siokas Grigorios
/
director, 10 percent owner, officer: Chief Executive Officer
01/16/2025
Buy
$0.84
47,904
$40K
4.14M
NASDAQ
COSM
Cosmos Health
Siokas Grigorios
/
director, 10 percent owner, officer: Chief Executive Officer
01/17/2025
Buy
$0.86
29,158
$25K
4.16M
NASDAQ
COSM
Cosmos Health
Siokas Grigorios
/
director, 10 percent owner, officer: Chief Executive Officer
01/15/2025
Buy
$0.80
62,500
$50K
4.09M
NASDAQ
CYTK
Cytokinetics
Malik Fady Ibraham
/
officer: EVP Research & Development
01/21/2025
Sell
$45.92
2,000
$92K
116,071
NYSE
EW
Edwards Lifesciences
Lippis Daniel J.
/
officer: CVP, JAPAC
01/16/2025
Sell
$68.76
500
$34K
23,189
NYSE
EW
Edwards Lifesciences
BOBO DONALD E JR
/
officer: CVP,Strategy/Corp Development
01/16/2025
Sell
$68.75
5,000
$344K
46,935
NASDAQ
FTRE
Fortrea
Pike Thomas
/
director, officer: Chief Executive Officer
01/13/2025
Sell
$18.04
11,268
$203K
159,868
NASDAQ
GILD
Gilead Sciences
Dickinson Andrew D
/
officer: Chief Financial Officer
01/15/2025
Sell
$91.35
2,500
$228K
129,873
NASDAQ
GYRE
Gyre Therapeutics
Ma Songjiang
/
director, officer: President
01/15/2025
Sell
$10.85
2,000
$22K
2.91M
NASDAQ
GYRE
Gyre Therapeutics
Ma Songjiang
/
director, officer: President
01/17/2025
Sell
$10.72
2,000
$21K
2.91M
NASDAQ
GYRE
Gyre Therapeutics
Ma Songjiang
/
director, officer: President
01/14/2025
Sell
$10.39
2,000
$21K
2.91M
NASDAQ
GYRE
Gyre Therapeutics
Ma Songjiang
/
director, officer: President
01/16/2025
Sell
$10.71
2,000
$21K
2.91M
NASDAQ
HRMY
Harmony Biosciences
Dierks Jeffrey
/
officer: CHIEF COMMERCIAL OFFICER
01/21/2025
Sell
$40.00
1,123
$45K
0
NASDAQ
HRMY
Harmony Biosciences
Dierks Jeffrey
/
officer: CHIEF COMMERCIAL OFFICER
01/16/2025
Sell
$37.41
29,475
$1.103M
0
NASDAQ
HRMY
Harmony Biosciences
Dierks Jeffrey
/
officer: CHIEF COMMERCIAL OFFICER
01/15/2025
Sell
$37.01
10,507
$389K
0
NASDAQ
HRMY
Harmony Biosciences
Dierks Jeffrey
/
officer: CHIEF COMMERCIAL OFFICER
01/13/2025
Sell
$37.04
7,180
$266K
0
NASDAQ
HCAT
Health Catalyst
Llewelyn Linda
/
officer: Chief People Officer
01/15/2025
Sell
$5.80
6,442
$37K
92,260
NASDAQ
IGMS
IGM Biosciences
Weber Steven
/
officer: PRINCIPAL ACCOUNTING OFFICER
01/15/2025
Sell
$1.70
1,122
$2K
30,582
NASDAQ
IONS
Ionis Pharmaceuticals
BENNETT C FRANK
/
officer: EVP, Chief Scientific Officer
01/16/2025
Sell
$32.90
6,752
$222K
90,866
NASDAQ
IONS
Ionis Pharmaceuticals
O'NEIL PATRICK R.
/
officer: EVP CLO & General Counsel
01/16/2025
Sell
$32.83
7,360
$242K
61,203
NASDAQ
IONS
Ionis Pharmaceuticals
Birchler Brian
/
officer: EVP, Corp and Development Ops
01/16/2025
Sell
$32.70
5,400
$177K
55,051
NASDAQ
IONS
Ionis Pharmaceuticals
Schneider Eugene
/
officer: EVP, Chf Clinical Develop Ofcr
01/16/2025
Sell
$32.79
6,523
$214K
58,508
NASDAQ
IONS
Ionis Pharmaceuticals
Devers Shannon L.
/
officer: EVP, Chief Human Resources Ofc
01/16/2025
Sell
$32.78
4,267
$140K
15,937
NASDAQ
IONS
Ionis Pharmaceuticals
Swayze Eric
/
officer: EVP Research
01/16/2025
Sell
$32.70
22
$719
184
NASDAQ
IONS
Ionis Pharmaceuticals
Geary Richard S
/
officer: EVP, Chief Development Officer
01/16/2025
Sell
$32.86
7,072
$232K
96,663
NASDAQ
IONS
Ionis Pharmaceuticals
Swayze Eric
/
officer: EVP Research
01/16/2025
Sell
$32.84
7,154
$235K
45,670
NASDAQ
IONS
Ionis Pharmaceuticals
Baroldi Joseph
/
officer: EVP, Chief Business Officer
01/16/2025
Sell
$32.70
1,029
$34K
3,071
NASDAQ
IONS
Ionis Pharmaceuticals
HOUGEN ELIZABETH L
/
officer: EVP, Finance & CFO
01/16/2025
Sell
$32.81
8,870
$291K
107,885
NASDAQ
IONS
Ionis Pharmaceuticals
Baroldi Joseph
/
officer: EVP, Chief Business Officer
01/16/2025
Sell
$32.70
3,401
$111K
25,017
NASDAQ
IONS
Ionis Pharmaceuticals
Monia Brett P
/
director, officer: Chief Executive Officer
01/16/2025
Sell
$32.63
33,445
$1.091M
207,396
NASDAQ
LNTH
Lantheus
Thrall James H
/
director
01/15/2025
Sell
$94.76
1,000
$95K
33,207
NASDAQ
MDGL
Madrigal Pharmaceuticals
Kelley Shannon T
/
officer: General Counsel
01/17/2025
Sell
$273.41
277
$76K
7,705
NASDAQ
MDGL
Madrigal Pharmaceuticals
Taub Rebecca
/
director, officer: Pres., R&D, and CMO
01/17/2025
Sell
$273.41
1,689
$462K
457,310
NASDAQ
MDGL
Madrigal Pharmaceuticals
Waltermire Robert E.
/
officer: Senior VP, Chief Pharma Dev.
01/17/2025
Sell
$273.41
442
$121K
5,058
TSX.V
MRVL
Marvel Biosciences
Meintjes Willem A
/
officer: Chief Financial Officer
01/15/2025
Sell
$118.33
1,500
$177K
111,211
TSX.V
MRVL
Marvel Biosciences
Casper Mark
/
officer: EVP & Chief Legal Officer
01/17/2025
Sell
$123.08
7,755
$954K
0
NASDAQ
MGTX
MeiraGTx
Giroux Richard
/
officer: CFO & COO
01/21/2025
Sell
$6.29
24,000
$151K
849,947
NASDAQ
MRSN
Mersana Therapeutics
Lowinger Timothy B
/
officer: SVP, Chief Sci.&Tech. Officer
01/16/2025
Sell
$0.58
8,048
$5K
257,673
NASDAQ
MRSN
Mersana Therapeutics
Carvajal Alejandra
/
officer: SVP, Chief Legal Officer
01/14/2025
Sell
$0.66
3,330
$2K
69,344
NASDAQ
MRSN
Mersana Therapeutics
Carvajal Alejandra
/
officer: SVP, Chief Legal Officer
01/15/2025
Sell
$0.63
952
$600
70,892
NASDAQ
MRSN
Mersana Therapeutics
Protopapas Anna
/
director
01/16/2025
Sell
$0.58
8,637
$5K
168,041
NASDAQ
MRSN
Mersana Therapeutics
DeSchuytner Brian
/
officer: SVP, COO & CFO
01/14/2025
Sell
$0.66
3,713
$2K
105,111
NASDAQ
MRSN
Mersana Therapeutics
Bala Mohan
/
officer: SVP, Chief Development Officer
01/16/2025
Sell
$0.58
5,939
$3K
68,872
NASDAQ
MRSN
Mersana Therapeutics
DeSchuytner Brian
/
officer: SVP, COO & CFO
01/15/2025
Sell
$0.63
2,331
$1K
109,030
NASDAQ
MRSN
Mersana Therapeutics
Mandelia Ashish
/
officer: VP, Chief Accounting Officer
01/16/2025
Sell
$0.58
3,554
$2K
57,519
NASDAQ
MRSN
Mersana Therapeutics
Lowinger Timothy B
/
officer: SVP, Chief Sci.&Tech. Officer
01/14/2025
Sell
$0.66
3,483
$2K
242,932
NASDAQ
MRSN
Mersana Therapeutics
Carvajal Alejandra
/
officer: SVP, Chief Legal Officer
01/16/2025
Sell
$0.58
5,096
$3K
78,296
NASDAQ
MRSN
Mersana Therapeutics
Lowinger Timothy B
/
officer: SVP, Chief Sci.&Tech. Officer
01/15/2025
Sell
$0.63
1,794
$1K
245,930
NASDAQ
MRSN
Mersana Therapeutics
Mandelia Ashish
/
officer: VP, Chief Accounting Officer
01/14/2025
Sell
$0.66
1,007
$665
49,396
NASDAQ
MRSN
Mersana Therapeutics
DeSchuytner Brian
/
officer: SVP, COO & CFO
01/16/2025
Sell
$0.58
8,470
$5K
121,393
NASDAQ
MRSN
Mersana Therapeutics
Mandelia Ashish
/
officer: VP, Chief Accounting Officer
01/15/2025
Sell
$0.63
1,791
$1K
52,388
NASDAQ
MRSN
Mersana Therapeutics
Protopapas Anna
/
director
01/15/2025
Sell
$0.63
6,191
$4K
155,428
NASDAQ
MRSN
Mersana Therapeutics
Protopapas Anna
/
director
01/14/2025
Sell
$0.66
11,534
$8K
144,869
NASDAQ
MRSN
Mersana Therapeutics
Huber Martin H. Jr.
/
director, officer: President, CEO
01/16/2025
Sell
$0.58
4,514
$3K
122,875
NASDAQ
MRSN
Mersana Therapeutics
Bala Mohan
/
officer: SVP, Chief Development Officer
01/14/2025
Sell
$0.66
3,253
$2K
60,228
NASDAQ
MLYS
Mineralys Therapeutics
Congleton Jon
/
director, officer: Chief Executive Officer
01/13/2025
Sell
$9.06
18,333
$166K
877,608
NASDAQ
MLYS
Mineralys Therapeutics
Levy Adam Scott
/
officer: CFO and Secretary
01/13/2025
Sell
$9.63
100
$963
226,097
NASDAQ
MLYS
Mineralys Therapeutics
Levy Adam Scott
/
officer: CFO and Secretary
01/13/2025
Sell
$9.09
10,657
$97K
226,197
NASDAQ
MIRM
Mirum Pharmaceuticals
Quan Joanne
/
officer: CHIEF MEDICAL OFFICER
01/17/2025
Sell
$45.86
6,969
$320K
5,649
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
10 percent owner
01/10/2025
Buy
$7.91
120,237
$951K
3.68M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
10 percent owner
01/10/2025
Buy
$8.79
26,326
$231K
3.70M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
10 percent owner
01/13/2025
Buy
$6.56
452,378
$2.968M
4.16M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
10 percent owner
01/14/2025
Buy
$5.88
330,046
$1.941M
4.49M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
10 percent owner
01/10/2025
Buy
$6.81
573,437
$3.905M
3.56M
NASDAQ
NEOG
Neogen
ADENT JOHN EDWARD
/
officer: CEO
01/16/2025
Buy
$11.03
23,035
$254K
269,164
NASDAQ
NEOG
Neogen
Naemura David H.
/
officer: CFO
01/16/2025
Buy
$11.11
14,800
$164K
61,434
NASDAQ
NBIX
Neurocrine Biosciences
Gano Kyle
/
director, officer: Chief Executive Officer
01/15/2025
Sell
$141.50
4,812
$681K
135,392
NASDAQ
NBIX
Neurocrine Biosciences
Gano Kyle
/
director, officer: Chief Executive Officer
01/15/2025
Sell
$141.50
60,188
$8.517M
135,392
NASDAQ
NVCR
Novocure
Paravasthu Mukund
/
officer: Chief Operating Officer
01/11/2025
Sell
$26.81
2,160
$58K
31,437
NASDAQ
OFIX
Orthofix Medical
Andrews Julie
/
officer: CFO
01/16/2025
Sell
$17.89
4,655
$83K
28,312
NYSEAMEX
OSTX
OS Therapies
Auerbach Shalom
/
10 percent owner
01/15/2025
Sell
$6.74
16,720
$113K
2.53M
NYSE
OWLT
Owlet
Harris Jonathan
/
officer: President & CRO
01/16/2025
Sell
$4.30
7,740
$33K
280,877
NYSE
OWLT
Owlet
Harris Jonathan
/
officer: President & CRO
01/07/2025
Sell
$4.45
16,439
$73K
288,617
NYSE
OWLT
Owlet
Crawford Amanda
/
officer: Chief Financial Officer
01/16/2025
Sell
$4.30
182
$783
150,508
NYSE
PHR
Phreesia
Hoffman Allison C
/
officer: General Counsel & Secretary
01/15/2025
Sell
$26.98
1,089
$29K
154,552
NYSE
PHR
Phreesia
Roberts Evan
/
officer: Chief Operating Officer
01/15/2025
Sell
$26.98
1,785
$48K
768,208
NYSE
PHR
Phreesia
Hoffman Allison C
/
officer: General Counsel & Secretary
01/15/2025
Sell
$26.87
3,496
$94K
155,641
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
01/15/2025
Sell
$26.98
1,946
$53K
237,265
NYSE
PHR
Phreesia
Hui Yvonne
/
officer: Principal Accounting Officer
01/15/2025
Sell
$26.87
381
$10K
25,774
NYSE
PHR
Phreesia
Hui Yvonne
/
officer: Principal Accounting Officer
01/14/2025
Sell
$26.38
362
$10K
26,155
NYSE
PHR
Phreesia
VanDuyn Amy Beth
/
officer: SVP, Human Resources
01/15/2025
Sell
$26.98
604
$16K
115,029
NYSE
PHR
Phreesia
Indig Chaim
/
director, officer: Chief Executive Officer
01/15/2025
Sell
$26.98
2,990
$81K
1.26M
NYSE
PHR
Phreesia
Gandhi Balaji
/
officer: Chief Financial Officer
01/15/2025
Sell
$26.98
836
$23K
147,673
NASDAQ
PDEX
Pro-Dex
CABILLOT RAYMOND E
/
director, 10 percent owner:
01/10/2025
Sell
$47.76
1,200
$57K
359,646
NASDAQ
PDEX
Pro-Dex
CABILLOT RAYMOND E
/
director, 10 percent owner:
01/15/2025
Sell
$45.18
1,879
$85K
352,996
NASDAQ
PDEX
Pro-Dex
CABILLOT RAYMOND E
/
director, 10 percent owner:
01/14/2025
Sell
$45.18
1,147
$52K
354,875
NASDAQ
PDEX
Pro-Dex
CABILLOT RAYMOND E
/
director, 10 percent owner:
01/13/2025
Sell
$46.66
3,624
$169K
356,022
NASDAQ
LUNG
Pulmonx
French Glendon E. III
/
director
01/16/2025
Sell
$6.53
2,326
$15K
1.07M
NASDAQ
LUNG
Pulmonx
French Glendon E. III
/
director
01/17/2025
Sell
$6.50
2,221
$14K
1.07M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
01/14/2025
Buy
$0.74
11,547
$9K
14.98M
NASDAQ
RXST
RxSight
Corley Jesse Anderson
/
director
01/15/2025
Buy
$31.19
1,443
$45K
1,443
NASDAQ
RXST
RxSight
Corley Jesse Anderson
/
director
01/16/2025
Buy
$31.13
1,767
$55K
3,210
NASDAQ
SERA
Sera Prognostics
Kearney Paul
/
officer: Chief Data Officer
01/10/2025
Sell
$8.06
1,144
$9K
163,470
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$7.18
1,881
$14K
4,872
NASDAQ
SERA
Sera Prognostics
Jackson Benjamin
/
officer: General Counsel
01/13/2025
Sell
$6.38
7,912
$50K
120,561
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$7.18
2
$14
6
NASDAQ
SERA
Sera Prognostics
Kearney Paul
/
officer: Chief Data Officer
01/10/2025
Sell
$7.36
12,275
$90K
164,614
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$8.03
921
$7K
6,153
NASDAQ
SERA
Sera Prognostics
Jackson Benjamin
/
officer: General Counsel
01/10/2025
Sell
$8.05
1,231
$10K
128,473
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/13/2025
Sell
$6.39
2,415
$15K
1,814
NASDAQ
SERA
Sera Prognostics
Harrison Robert Gardner
/
officer: Chief Information Officer
01/13/2025
Sell
$6.47
2,264
$15K
114,573
NASDAQ
SERA
Sera Prognostics
Jackson Benjamin
/
officer: General Counsel
01/10/2025
Sell
$7.36
12,041
$89K
129,704
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$7.18
2,692
$19K
7,074
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/13/2025
Sell
$6.39
3,458
$22K
2,695
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/14/2025
Sell
$6.29
2,695
$17K
0
NASDAQ
SERA
Sera Prognostics
Harrison Robert Gardner
/
officer: Chief Information Officer
01/10/2025
Sell
$8.01
1,837
$15K
116,837
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$8.03
1,674
$13K
11,114
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$8.03
643
$5K
4,229
NASDAQ
SERA
Sera Prognostics
Harrison Robert Gardner
/
officer: Chief Information Officer
01/10/2025
Sell
$7.30
12,372
$90K
118,674
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/13/2025
Sell
$6.39
3
$19
2
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$7.18
4,896
$35K
12,788
NASDAQ
SERA
Sera Prognostics
Aerts Austin
/
officer: Chief Financial Officer
01/10/2025
Sell
$8.06
2,431
$20K
283,325
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/13/2025
Sell
$6.39
6,287
$40K
4,827
NASDAQ
SERA
Sera Prognostics
Jackson Benjamin
/
officer: General Counsel
01/14/2025
Sell
$6.20
8,407
$52K
112,154
NASDAQ
SERA
Sera Prognostics
Phillips Joshua
/
director
01/10/2025
Sell
$8.03
1
$8
5
NASDAQ
SGHT
Sight Sciences
HAYDEN JEREMY B.
/
officer: Chief Legal Officer
01/17/2025
Sell
$2.78
6,922
$19K
145,091
NASDAQ
SGHT
Sight Sciences
Badawi Paul
/
director, officer: President and CEO
01/16/2025
Sell
$2.92
24,819
$73K
5.68M
NASDAQ
SGHT
Sight Sciences
Badawi David
/
director, officer: Chief Technology Officer
01/17/2025
Sell
$2.78
5,423
$15K
1.74M
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
01/14/2025
Buy
$21.46
21,155
$454K
10.87M
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
01/16/2025
Buy
$21.50
8,221
$177K
10.88M
NASDAQ
TYRA
Tyra Biosciences
Kjellson Nina S
/
director
01/17/2025
Sell
$16.40
461
$8K
447,396
NASDAQ
TYRA
Tyra Biosciences
Kjellson Nina S
/
director
01/16/2025
Sell
$16.29
835
$14K
447,857
NASDAQ
TYRA
Tyra Biosciences
Kjellson Nina S
/
director
01/21/2025
Sell
$16.36
3,993
$65K
3.71M
NASDAQ
TYRA
Tyra Biosciences
Kjellson Nina S
/
director
01/17/2025
Sell
$16.40
12,808
$210K
3.71M
NASDAQ
TYRA
Tyra Biosciences
Kjellson Nina S
/
director
01/16/2025
Sell
$16.29
6,944
$113K
3.72M
NASDAQ
VYGR
Voyager Therapeutics
Carter Todd Alfred
/
officer: Chief Scientific Officer
01/14/2025
Sell
$5.13
1,191
$6K
86,436
NASDAQ
VYGR
Voyager Therapeutics
Swartz Robin
/
officer: COO & CBO
01/14/2025
Sell
$5.09
3,087
$16K
109,241
NASDAQ
VYNE
VYNE Therapeutics
LEPORE PATRICK G
/
director
01/15/2025
Buy
$2.92
15,000
$44K
51,472
NASDAQ
ZYME
Zymeworks
EcoR1 Capital, LLC
/
director, 10 percent owner:
01/16/2025
Buy
$13.89
121,681
$1.690M
15.70M
NASDAQ
ZYME
Zymeworks
EcoR1 Capital, LLC
/
director, 10 percent owner:
01/17/2025
Buy
$13.87
19,748
$274K
15.72M
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.